Results 21 to 30 of about 24,009 (265)

The effectiveness and cost of lansoprazole and pantoprazole for stress ulcer prophylaxis in intensive care unit [PDF]

Pharmaciana, 2021
The incidence of bleeding is increased in high risk patients with critical conditions in Intensive Care Unit (ICU). Appropriate prophylaxis medicine is necessary to reduce the incidence of stress ulcer bleeding during hospitalization in ICU which further
Mega Octavia, Zullies Ikawati, Tri Murti Andayani   +2 more
doaj   +1 more source

Efficacy and Safety of Keverprazan Compared With Lansoprazole in the Treatment of Duodenal Ulcer: A Phase III, Randomized, Double-Blind, Multicenter Trial

Clinical and Translational Gastroenterology, 2023
INTRODUCTION: Keverprazan is a novel potassium-competitive acid blocker for the treatment of acid-related disorders requiring potent acid inhibition.
N. Tan, Xinpu Miao, Ai-Jun Liao, Cheng-Xia Liu, Hao-jie Wu, Honghui Chen, Fangqiang Li, Qing-Hong Guo, Sheng-Bao Li, Yanping Tang, Minghui Xia, Youshou Liu, Xing Li, Huixin Chen, Xiao-wei Liu, Yan Zhang, Zhen-yu Zhang, Min-Hu Chen, Yinglian Xiao   +18 more
semanticscholar   +1 more source

Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial

International Journal of Molecular Sciences, 2023
Pseudoxanthoma elasticum (PXE) is characterized by low levels of inorganic pyrophosphate (PPi) and a high activity of tissue-nonspecific alkaline phosphatase (TNAP). Lansoprazole is a partial inhibitor of TNAP.
Belén Murcia Casas, J. L. Carrillo Linares, I. Baquero Aranda, J. Rioja Villodres, Vicente Merino Bohórquez, Andrés González Jiménez, Miguel Angel Rico Corral, R. Bosch, M. A. Sánchez Chaparro, M. García Fernández, P. Valdivielso   +10 more
semanticscholar   +1 more source

Vonoprazan non‐inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients

Journal of Gastroenterology and Hepatology, 2022
Duodenal ulcers, especially caused by increasingly drug‐resistant Helicobacter pylori, are a concern in Asia. We compared oral vonoprazan versus lansoprazole for efficacy (healing duodenal ulcers) and safety in non‐Japanese Asian patients.
X. Hou, Fandong Meng, Jiang-bing Wang, W. Sha, C. Chiu, W. Chung, Liqun Gu, K. Kudou, C. Chong, Shutian Zhang   +9 more
semanticscholar   +1 more source

Efficacy of soluble lansoprazole-impregnated beta-tricalcium phosphate for bone regeneration

Scientific Reports, 2022
The proton pump inhibitor lansoprazole has been previously identified to upregulate the expression and transcriptional activity of runt-related transcription factor 2 (Runx2) that promotes lineage commitment and differentiation of osteoprogenitor cells ...
Kenichi Mishima, Yuka Tsukagoshi Okabe, Masaaki Mizuno, Kinji Ohno, Hiroshi Kitoh, Shiro Imagama   +5 more
doaj   +1 more source

Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis

Alimentary Pharmacology and Therapeutics, 2022
Tegoprazan is a novel potassium‐competitive acid blocker used to treat acid‐related disorders.
Y. Cho, J. Kim, Hyun-Soo Kim, Tae-Oh Kim, J. Oh, S. Choi, J. Moon, Sang Kil Lee, S. Jung, Sung Soo Kim, H. Jung, Sang Pyo Lee, G. Cheon, M. Park, Hwoong-Yong Jung, K. Ko, I. Sung, S. Lee, J. Y. Lee, Soo Teik Lee, P. Rhee, Nayoung Kim, S. Hong, Hyun Jin Kim, Gwang Ha Kim, Kwang Jae Lee, S. Kim, W. Shin, O. Lee   +28 more
semanticscholar   +1 more source

Lansoprazole – Induce Black Hairy Tongue- A Case Report

Nepal Journal of Dermatology, Venereology & Leprology, 2017
Lansoprazole induced black hairy tongue has been rarely reported. The purpose of this paper is to report a case of lansoprazole induce black hairy tongue and review the literature.
Eliz Aryal, M Rajbhandari, Sabina Bhattarai   +2 more
doaj   +3 more sources

Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study

Diabetology & Metabolic Syndrome, 2023
Background Proton pump inhibitors (PPIs) are common and widely used for gastrointestinal-related disorders. Lansoprazole is one of PPIs with potential benefits of anti-inflammation, reduced oxidative stress, and anti-diabetes.
Ming-Hsun Lin, Wen‐Tung Wu, Yong-Chen Chen, Tsung-Kun Lin, Yu‐Ching Chou, Chien‐An Sun   +5 more
doaj   +1 more source

Proton Pump Inhibitor-Induced Fundic Gland Polyps With Massive Bleeding Regressed on Alternative Histamine 2 Receptor Antagonist Therapy. [PDF]

DEN Open
Abstract We report a case of massive bleeding from proton pump inhibitor (PPI)‐induced fundic gland polyps (FGPs) that regressed after switching to a histamine‐2 receptor antagonist (H2RA). A 46‐year‐old man with antiphospholipid syndrome had been receiving warfarin and lansoprazole for 4 years.
Ikeda R, Kaneko H, Sato H, Matsuoka Y, Hamaguchi T, Ikeda A, Goda Y, Sue S, Irie K, Maeda S.   +9 more
europepmc   +2 more sources

Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication

British Journal of Clinical Pharmacology, 2021
Helicobacter pylori (Hp) eradication plays a key role in the treatment and prevention of peptic ulcer diseases. Increasing clarithromycin resistance in Hp necessitates more effective treatments for eradication, such as bismuth‐containing quadruple ...
K. Y. Huh, H. Chung, Y. Kim, Seung Hwan Lee, Siddharth Bhatia, Y. Takanami, R. Nakaya, K. Yu   +7 more
semanticscholar   +1 more source